ArriVent BioPharma, Inc. Common Stock – NASDAQ:AVBP

ArriVent BioPharma, Inc. Common Stock stock price today

$18.6
-8.66
-31.77%
Financial Health
0
1
2
3
4
5
6
7
8
9

ArriVent BioPharma, Inc. Common Stock stock price monthly change

+48.23%
month

ArriVent BioPharma, Inc. Common Stock stock price quarterly change

+48.23%
quarter

ArriVent BioPharma, Inc. Common Stock key metrics

Market Cap
860.28M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
N/A
Revenue
N/A
EBITDA
N/A
Income
N/A
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

ArriVent BioPharma, Inc. Common Stock stock price history

ArriVent BioPharma, Inc. Common Stock stock forecast

ArriVent BioPharma, Inc. Common Stock financial statements

ArriVent BioPharma, Inc. Common Stock (NASDAQ:AVBP): Profit margin
2023 0 -69.33M
ArriVent BioPharma, Inc. Common Stock (NASDAQ:AVBP): Earnings per share (EPS)
2024-05-08 -0.84 -0.7
ArriVent BioPharma, Inc. Common Stock (NASDAQ:AVBP): Debt to assets
2023 163098000 11.80M 7.24%
ArriVent BioPharma, Inc. Common Stock (NASDAQ:AVBP): Cash Flow
2022 -43.63M 0 169.72M
2023 -55.84M 0 42.85M

ArriVent BioPharma, Inc. Common Stock alternative data

ArriVent BioPharma, Inc. Common Stock (NASDAQ:AVBP): Employee count
Feb 2024 42
Mar 2024 42
Apr 2024 40
May 2024 40
Jun 2024 40
Jul 2024 40
Dec 2024 40

ArriVent BioPharma, Inc. Common Stock other data

ArriVent BioPharma, Inc. Common Stock (NASDAQ:AVBP): Insider trades (number of shares)
Period Buy Sel
Jan 2024 222222 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
GORDON CARL L director, 10 percent owner:
Common Stock 222,222 $18 $3,999,996
Wednesday, 6 November 2024
marketbeat.com
Monday, 9 September 2024
globenewswire.com
Monday, 19 August 2024
zacks.com
Thursday, 15 August 2024
businesswire.com
Wednesday, 14 August 2024
globenewswire.com
Monday, 12 August 2024
globenewswire.com
Wednesday, 5 June 2024
globenewswire.com
Thursday, 16 May 2024
globenewswire.com
Wednesday, 8 May 2024
globenewswire.com
Monday, 22 April 2024
globenewswire.com
Thursday, 28 March 2024
businesswire.com
globenewswire.com
Monday, 5 February 2024
247wallst.com
Monday, 29 January 2024
Seeking Alpha
  • What's the price of ArriVent BioPharma, Inc. Common Stock stock today?

    One share of ArriVent BioPharma, Inc. Common Stock stock can currently be purchased for approximately $18.6.

  • When is ArriVent BioPharma, Inc. Common Stock's next earnings date?

    Unfortunately, ArriVent BioPharma, Inc. Common Stock's (AVBP) next earnings date is currently unknown.

  • Does ArriVent BioPharma, Inc. Common Stock pay dividends?

    No, ArriVent BioPharma, Inc. Common Stock does not pay dividends.

  • How much money does ArriVent BioPharma, Inc. Common Stock make?

    ArriVent BioPharma, Inc. Common Stock has a market capitalization of 860.28M. ArriVent BioPharma, Inc. Common Stock made a loss 69.33M US dollars in net income (profit) last year or -$0.7 on an earnings per share basis.

  • What is ArriVent BioPharma, Inc. Common Stock's stock symbol?

    ArriVent BioPharma, Inc. Common Stock is traded on the NASDAQ under the ticker symbol "AVBP".

  • What is ArriVent BioPharma, Inc. Common Stock's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of ArriVent BioPharma, Inc. Common Stock?

    Shares of ArriVent BioPharma, Inc. Common Stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does ArriVent BioPharma, Inc. Common Stock have?

    As Dec 2024, ArriVent BioPharma, Inc. Common Stock employs 40 workers.

  • When ArriVent BioPharma, Inc. Common Stock went public?

    ArriVent BioPharma, Inc. Common Stock is publicly traded company for just a year since IPO on 26 Jan 2024.

  • What is ArriVent BioPharma, Inc. Common Stock's official website?

    The official website for ArriVent BioPharma, Inc. Common Stock is arrivent.com.

  • How can i contact ArriVent BioPharma, Inc. Common Stock?

    ArriVent BioPharma, Inc. Common Stock can be reached via phone at +62 82774836.

ArriVent BioPharma, Inc. Common Stock company profile:

ArriVent BioPharma, Inc. Common Stock

arrivent.com
Exchange:

NASDAQ

Full time employees:

40

Industry:

Biotechnology

Sector:

Healthcare

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.

18 Campus Boulevard
Newtown Square, 19073

:
ISIN: US04272N1028
: